Evidence map›Paper›PMID 38149979›Full record

ArticleAging2023

Macrophage-specific deletion of Notch-1 induced M2 anti-inflammatory effect in atherosclerosis via activation of the PI3K-oxidative stress axis.

Mingming Zhang, Xiangyong Yue, Xueping Zhao, Yonggang Lu, Hongtao Liu, Zhe Zhang, Huan Ma, Xing Wang, Hanying Xing

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mingming ZhangClinical Medicine Research Center, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Xiangyong YueDepartment of Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Xueping ZhaoDepartment of Nursing, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Yonggang LuClinical Laboratory, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Hongtao LiuClinical Medicine Research Center, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Zhe ZhangClinical Medicine Research Center, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Huan MaClinical Medicine Research Center, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Xing WangClinical Medicine Research Center, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Hanying XingClinical Medicine Research Center, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Hebei General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNotch-1 signaling is significantly associated with the occurrence and development of atherosclerosis (AS). However, the molecular mechanisms underlying the specific deletion of Notch-1 in AS-associated macrophages are not fully understood. This study aimed to investigate the effects of Notch-1 in AS. METHODS AND

resultsTissue samples were obtained from atherosclerotic segments of human carotid arteries. Immunofluorescence staining showed that Notch-1 was significantly colocalized with macrophages (CD68+), and Notch-1 staining was increased in human vulnerable plaques. Notch-1

conclusionsThe specific deletion of Notch-1 in macrophage represses the formation and development of AS via the PI3K/AKT signaling pathway.

Indexed as

AtherosclerosisMacrophagesReceptor, Notch1AnimalsAnti-Inflammatory AgentsApolipoproteins EHumansMiceMice, Inbred C57BLOxidative StressPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAnti-Inflammatory AgentsApolipoproteins EPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptor, Notch1atherosclerosisexosomeNotch-1Notch-1Mac-KOPI3K/AKT

Identifiers

PMID38149979
PMCPMC10781475
OpenAlexW4390227705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.